Inventor

REISNER YAIR

IL37 patents

⚠️ This page may combine multiple inventors who share the name “REISNER YAIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REISNER YAIR

YEDA RES & DEV

Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells

Veto cells effective in preventing graft rejection and devoid of graft versus host potential

Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems

Bone marrow transplantation

Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoietic deficient immune systems

Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems

Combination therapy for a stable and long term engraftment

Animal model for hepatitis virus infection

Animal model for hepatitis virus infection

Veto cells effective in preventing graft rejection and devoid of graft versus host potential

Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion

Genetically modified anti-third party central memory T cells and use of same in immunotherapy

Methods of transplantation and disease treatment

Veto cells generated from memory T cells

Mammalian fetal pulmonary cells and therapeutic use of same

Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts

Animal model for hepatitis virus infection

Genetically modified anti-third party central memory T cells and use of same in immunotherapy

Veto cells generated from memory T cells

Human monoclonal antibodies to the hepatitis B surface antigen

Genetically modified anti-third party central memory T cells and use of same in immunotherapy

Veto cells generated from memory T cells

Genetically modified veto cells and use of same in immunotherapy

Methods of transplantation and disease treatment

Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion

Combination therapy for a stable and long term engraftment

Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment

Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment

Use of hematopoietic deficient cell transplanted chimeric nonhuman mammals as human bacterial toxin shock models

Human monoclonal antibodies to the hepatitis B surface antigen

Conditioning protocols and use of same for tissue regeneration

REISNER YAIR

Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance

Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment

Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment

Disease treatment via developing non-syngeneic graft transplantation

Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts

ARONOVICH ANNA

Methods for hematopoietic precursor mobilization